Silva E, Sallie R, Tibbs C, McFarlane I, Johnson P, Williams R
Institute of Liver Studies, King's College School of Medicine and Dentistry, London, UK.
J Hepatol. 1993 Sep;19(2):211-5. doi: 10.1016/s0168-8278(05)80573-2.
Despite several studies from continental Europe reporting a high prevalence of antibodies to the hepatitis C virus (HCV), there has been little evidence of such infection in patients from the United Kingdom. The use of the polymerase chain reaction combined with two separate second generation anti-HCV assays is reported here in 58 UK patients with well-documented autoimmune chronic active hepatitis. All patients were in corticosteroid induced remission. All sera were collected prospectively for the specific purpose of this study. HCV-RNA was not detected by use of the polymerase chain reaction in any of the patients and antibodies to HCV were only detected in one patient. No evidence was found for the involvement of the hepatitis C virus in UK patients with classical, corticosteroid sensitive autoimmune chronic active hepatitis.
尽管来自欧洲大陆的多项研究报告称丙型肝炎病毒(HCV)抗体的高流行率,但英国患者中几乎没有这种感染的证据。本文报道了在58例有充分记录的自身免疫性慢性活动性肝炎的英国患者中,使用聚合酶链反应结合两种单独的第二代抗HCV检测方法。所有患者均处于皮质类固醇诱导的缓解期。所有血清均为前瞻性收集用于本研究的特定目的。在任何患者中均未通过聚合酶链反应检测到HCV-RNA,仅在一名患者中检测到抗HCV抗体。未发现丙型肝炎病毒参与英国典型的、对皮质类固醇敏感的自身免疫性慢性活动性肝炎患者的证据。